Fevertree share price: what to expect from H1 results
Fevertree is trading 48% down from its high 10 months ago. With first half earnings up ahead, what is the outlook for this recent success story?
Fevertree has been an incredible success story since their 2014 initial public offering (IPO), with the company gaining almost 2,500% from IPO to the £41.61 peak less than four years later. However, the past ten months have been the most testing for shareholders, after the firm lost 48% if its value.
For the most part this is reflective of a shift out of upstart and into a relatively well established company, with the mixer maker finds it tough to keep up with sky high expectations. Investors have been very used to beating forecasts and upgrading their guidance, yet we are starting to see a slowing of this gravy train. The company releases their latest half-year earnings on 23 July, with competitor Britvic posting theirs a day later. Forecasts for revenue growth point towards a 16% rise; down from 40% and 66% in the prior two years. The decline in share price provides an improved dividend and earnings per share (EPS) outlook, yet this slowdown is certainly something that traders will be keeping a close eye on next week.
Industry-wide factors exposed by AG Barr
Today’s profit warning from AG Barr points towards a tough period for the drinks maker, with the company suffering from a wet early summer period and the implementation of the soft drinks sugar tax. Both factors could have an impact on Fevertree, and with July seeing two research houses lowering their price targets (Jefferies - 270p, and RBC - 340p), we are seeing optimism tempered somewhat ahead of next week.
It is clear that the company is struggling to keep up with market expectations, and thus we are stuck in a position where the company is still expected to post very reasonable growth levels which happen to be significantly lower than previous years. With those temporary factors also playing into estimates, it will be key to see the company’s outlook on whether this downward trajectory is fleeting or a permanent feature for the firm.
Fevertree technical analysis – no sign of a reversal yet
From a technical standpoint, the huge 2019 decline has brought the price into a new 18-month low, with the price briefly sliding below the critical December 2018 low of £21.12. We have seen the share price attempt a fightback last week, we are yet to see any signal that this sell-off is over. The price is starting to turn lower once again, and this raises the likeliness of another leg lower to build on the bearish breakdown below £21.12. To the upside, a more bullish picture emerges with a break through the £24.43 providing a break from the recent trend of lower highs and lower lows. Given the highly oversold nature of this share, the upcoming earnings release will be absolutely crucial, for if we can see the price rally through that £24.43 swing high, a new bullish phase could start to take shape. However, with this major historical level broken, this release will be critical in staving off another sharp decline for the widely praised company.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
- Forex
- Shares
- Indices
See more forex live prices
See more shares live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
See more indices live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.